LifeScience Biologics
SOPHiA GENETICS a cloud-native healthcare technology company and a global leader in data-driven medicine, announced that it is collaborating with Microsoft...
May 31, 2024 | News
Thermo Fisher Scientific in Japan is pleased to announce that, as of 22 April 2024, Takara Bio Inc. has begun large-scale viral vector contract manufacturi...
May 30, 2024 | News
ProBioGen, a leading contract development and manufacturing organization (CDMO), known for its innovative solutions in cell engineering and bioproces...
May 30, 2024 | News
Tyligand Bioscience, a clinical-stage biotechnology company focused on the discovery and development of innovative cancer therapies, announced that the fir...
May 27, 2024 | News
Providence Therapeutic Holdings Inc. ("Providence"), a messenger RNA (mRNA) and lipid nanoparticle platform company engaged in the development of vaccines ...
May 24, 2024 | News
Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody disc...
May 23, 2024 | News
Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...
May 22, 2024 | News
Duoning Biotechnology Group ("Duoning"), a leading one-stop bioprocess provider in China, today announced a strategic partnership with Bioelectronica,...
May 21, 2024 | News
Innovent Biologics, Inc., a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatm...
May 21, 2024 | News
AstraZeneca intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates (ADCs), enhancing global s...
May 20, 2024 | News
“Approval of the Axonics recharge-free system is welcome news for Australians with bladder and bowel dysfunction,” said...
May 17, 2024 | News
Brii Biosciences Limited a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet need,...
May 14, 2024 | News
-- The companies share design of global Phase 3 trial, iMMagine-3; will evaluate anito-cel in patients exposed to both an immunomodulatory (lMi...
May 10, 2024 | News
Takara Bio USA, Inc., a wholly owned subsidiary of Takara Bio Inc., announced the launch of the Lenti-X™ Transduction Sponge, a first-to-market disso...
May 07, 2024 | News
Most Read
Bio Jobs
News
Editor Picks